Special Issue "From Nanotechnology to Nanomedicine: Past, Present and Future"
Deadline for manuscript submissions: 29 February 2024 | Viewed by 4543
Interests: molecular virology; bionanotechnology; molecular biology; immunology
Special Issues, Collections and Topics in MDPI journals
There are two ways of transferring information: 1) chronological, as a gradual evolutional accumulation of knowledge and 2) logical, which ranges from strict definitions to simple theory and more general concepts. Despite advances in nanotechnology and medical nanomaterials, there is no future without the past. The rapid progress in biopolymer isolation (proteins, polysaccharides, polyhydroxyalkanoates, polyphenols and nucleic acids) from natural sources, the chemical synthesis of novel biomimetics (nucleotides, amino acids, polymers and artificial enzymes) and composite materials (glycoproteins, proteoglycans, lipopolysaccharides and so on) as well as construction of inorganic and organic nanomaterials and even semisynthetic organisms (bacteria with six nucleotide bases instead of the classical four that encode 152 amino acids) open up new opportunities to attain higher levels of medicine and accelerate further development. New ideas of healthy living may be derived from the forgotten data of previous experiments. Comparative analysis of the advantages and disadvantages of nanostructures for medical diagnostics, vaccines and treatment could greatly benefit the scientific community.
Dr. Morozova Olga
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- natural and synthetic polymers
- composite materials
- side products of biodegradation
The below list represents only planned manuscripts. Some of these manuscripts have not been received by the Editorial Office yet. Papers submitted to MDPI journals are subject to peer-review.
Title: Bedaquiline-loaded solid lipid nanoparticles drug delivery in the management of non-small-cell lung cancer (NSCLC)
Highlights: BQ-loaded SLN might be used in this fashion to effectively carry the drug into the tumour tissue, perhaps lower the dosage, avoid harming healthy organs or tissues, and possibly even reverse MDR in tumours. This research determined the BQ-loaded SLN would be more effective than using either BQ suspension in treating lung cancer.